Top Official at Memorial Sloan Kettering Resigns After Failing to Disclose Industry Ties (2018)

News Report · ProPublica (with The New York Times) · September 13, 2018

ProPublica's report on Baselga's resignation as MSK chief medical officer and physician-in-chief, days after ProPublica and the Times documented undisclosed industry payments in dozens of journal articles.

Dr. José Baselga, the chief medical officer of Memorial Sloan Kettering Cancer Center, resigned on Thursday amid reports that he had failed to disclose millions of dollars in payments from health care companies in dozens of research articles.

Article body, opening paragraph

ProPublica's report on Baselga's resignation as MSK chief medical officer and physician-in-chief, days after ProPublica and the Times documented undisclosed industry payments in dozens of journal articles. News reporting, no funder statement on the page. Names: Jose Baselga, Craig B. Thompson (CEO), Lisa DeAngelis (acting physician-in-chief). The article records $3.5 million in Open Payments to Baselga and a further ~$250,000 in cash and options from Infinity Pharmaceuticals, a company with no FDA-approved product and therefore no reporting duty. Study type: news.